# Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes

> **NCT00747409** · PHASE4 · UNKNOWN · sponsor: **Munich Municipal Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** insulin aspart and detemir (NovoRapid, Levemir)
- **DRUG:** human regular insulin and NPH insulin (Actrapid, Protaphne)

## Key facts

- **NCT ID:** NCT00747409
- **Lead sponsor:** Munich Municipal Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-07
- **Primary completion:** 2009-03
- **Final completion:** 2009-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2008-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00747409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00747409, "Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00747409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*